New York State Common Retirement Fund Bio Xcel Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.14 - $2.97 $113 - $297	-100 Reduced 36.63%	173 $0
Q4 2023 Feb 01, 2024	SELL	$2.32 - $5.51 $71 - $170	-31 Reduced 10.2%	273 $1,000
Q3 2023 Nov 07, 2023	SELL	$2.49 - $11.85 $26,511 - $126,166	-10,647 Reduced 97.22%	304 $1,000
Q2 2023 Aug 07, 2023	BUY	$6.39 - $28.58 $421 - $1,886	66 Added 0.61%	10,951 $73,000
Q1 2023 May 02, 2023	SELL	$17.7 - $33.24 $12,142 - $22,802	-686 Reduced 5.93%	10,885 $203,000
Q4 2022 Jan 30, 2023	SELL	$10.25 - $22.43 $112 - $246	-11 Reduced 0.09%	11,571 $249,000
Q3 2022 Nov 08, 2022	BUY	$11.19 - $17.89 $637 - $1,019	57 Added 0.49%	11,582 $137,000
Q2 2022 Aug 04, 2022	SELL	$9.03 - $21.55 $216 - $517	-24 Reduced 0.21%	11,525 $152,000
Q1 2022 May 05, 2022	SELL	$15.0 - $22.83 $375 - $570	-25 Reduced 0.22%	11,549 $241,000
Q4 2021 Feb 02, 2022	BUY	$20.12 - $35.09 $462 - $807	23 Added 0.2%	11,574 $235,000
Q3 2021 Nov 02, 2021	SELL	$23.84 - $32.03 $89,614 - $120,400	-3,759 Reduced 24.55%	11,551 $351,000
Q2 2021 Aug 02, 2021	SELL	$29.06 - $38.83 $196,445 - $262,490	-6,760 Reduced 30.63%	15,310 $445,000
Q1 2021 May 11, 2021	BUY	$39.04 - $64.6 $397,036 - $656,982	10,170 Added 85.46%	22,070 $953,000
Q4 2020 Feb 08, 2021	BUY	$42.46 - $56.58 $93,412 - $124,476	2,200 Added 22.68%	11,900 $550,000
Q2 2020 Aug 07, 2020	BUY	$17.62 - $58.71 $59,908 - $199,614	3,400 Added 53.97%	9,700 $514,000
Q1 2020 May 06, 2020	SELL	$12.26 - $41.14 $35,554 - $119,306	-2,900 Reduced 31.52%	6,300 $141,000
Q2 2019 Aug 09, 2019	BUY	$8.99 - $11.79 $82,708 - $108,467	9,200 New	9,200 $101,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account